home >> news

HLS CUSTOMERS CONTINUE TO BE INVOLED IN PHARMA CORRUPTION

Monday, 27th February

In recent years, Big Pharma has forked out billions of dollars to settle scandals involving improper promotion of medicines in the United States. Now bribes paid to foreign doctors and other state employees are shaping up as the next major legal liability threat for the industry. A Reuters examination of U.S. Securities and Exchange Commission (SEC) filings by the world's top 10 drug companies has found that eight of them recently warned of potential costs related to charges of corruption in overseas markets.

One factor driving the trend is a search for new business. Companies whose profit margins have been squeezed in the developed world are increasingly turning to thinly regulated emerging markets for growth. At the same time, U.S. and European governments are toughening up on bribes paid by companies overseas. The U.S. Foreign Corrupt Practices Act and Britain's new Bribery Act, which came into force last July, are both targeting drugs companies for special scrutiny, providing new impetus for the industry to clean up its act.

Full story: http://www.reuters.com/article/2012/02/28/us-pharma-corruption-idUSTRE81R0S720120228

Related story - Pharma scams in India:
http://ibnlive.in.com/generalnewsfeed/news/cbi-unearths-medicine-supply-scam-in-delhi-government/968254.html

Share

 
Contact | Disclaimer | Legal